Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2012

Feb 22, 2012

29875_dirs_2012-02-22_5736959f-d990-4eda-80ff-bb8c3ead8777.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-02-21

Reporting Person: Brennan Troyen A (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-21 Common Stock M 96354 $28.10 Acquired 112818.1987 Direct
2012-02-21 Common Stock S 96354 $44.03 Disposed 16464.1987 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-21 Stock Option $28.10 M 96354 Disposed 2016-04-01 Common Stock (96354) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (pep) 11027.1987 Direct
Common Stock (restricted) 48937 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $36.23 2017-04-01 Common Stock (103267) 103267 Direct
Stock Option $28.26 2018-11-17 Common Stock (106160) 106160 Direct
Stock Option $34.96 2018-04-01 Common Stock (66987) 66987 Direct

Footnotes

F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.01 and $44.08 per share.

F2: Option became exercisable in three equal annual installments, commencing 4/1/2010.

F3: Option became exercisable in three equal annual installments, commencing 4/1/2011.

F4: Option became exercisable in three equal annual installments, commencing 11/17/2011.

F5: Option becomes exercisable in four equal annual installments, commencing 4/1/2012.